210 related articles for article (PubMed ID: 35605128)
21. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
Li Y; Lee Y; Port FK; Robinson BM
Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
[TBL] [Abstract][Full Text] [Related]
22. Conditional cross-design synthesis estimators for generalizability in Medicaid.
Degtiar I; Layton T; Wallace J; Rose S
Biometrics; 2023 Dec; 79(4):3859-3872. PubMed ID: 37018228
[TBL] [Abstract][Full Text] [Related]
23. Bounding Bias Due to Selection.
Smith LH; VanderWeele TJ
Epidemiology; 2019 Jul; 30(4):509-516. PubMed ID: 31033690
[TBL] [Abstract][Full Text] [Related]
24. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
Masarwa R; Platt RW; Filion KB
Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
[TBL] [Abstract][Full Text] [Related]
25. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
Fewell Z; Davey Smith G; Sterne JA
Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Bias Analysis of the Association between Occupational Radiation Exposure and Ischemic Heart Disease Mortality in UK Nuclear Workers.
de Vocht F; Martin RM; Hidajat M; Wakeford R
Radiat Res; 2021 Dec; 196(6):574-586. PubMed ID: 34370860
[TBL] [Abstract][Full Text] [Related]
27. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
Thompson CN; Hughes S; Ngai S; Baumgartner J; Wang JC; McGibbon E; Devinney K; Luoma E; Bertolino D; Hwang C; Kepler K; Del Castillo C; Hopkins M; Lee H; DeVito AK; Rakeman JL; ; Fine AD
MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):712-716. PubMed ID: 33983915
[TBL] [Abstract][Full Text] [Related]
28. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
[TBL] [Abstract][Full Text] [Related]
29. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Panel Estimate-Based Health Surveillance of SARS-CoV-2 Infection Rates to Inform Public Health Policy: Model Development and Validation.
Oehmke JF; Oehmke TB; Singh LN; Post LA
J Med Internet Res; 2020 Sep; 22(9):e20924. PubMed ID: 32915762
[TBL] [Abstract][Full Text] [Related]
31. Incorporating and addressing testing bias within estimates of epidemic dynamics for SARS-CoV-2.
Suhail Y; Afzal J; Kshitiz
BMC Med Res Methodol; 2021 Jan; 21(1):11. PubMed ID: 33413154
[TBL] [Abstract][Full Text] [Related]
32. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.
Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Jones HE; Larsen DA; Dennehy JJ; McNairy M; Borrell LN; Nash D
Commun Med (Lond); 2023 Jun; 3(1):92. PubMed ID: 37391483
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jun; ():. PubMed ID: 35765564
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.
Venugopal U; Jilani N; Rabah S; Shariff MA; Jawed M; Mendez Batres A; Abubacker M; Menon S; Pillai A; Shabarek N; Kasubhai M; Dimitrov V; Menon V
Int J Infect Dis; 2021 Jan; 102():63-69. PubMed ID: 33075539
[TBL] [Abstract][Full Text] [Related]
36. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
37. Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID-19.
Tattan-Birch H; Marsden J; West R; Gage SH
Addiction; 2021 May; 116(5):982-984. PubMed ID: 33226690
[No Abstract] [Full Text] [Related]
38. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
Cai B; Small DS; Have TR
Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
[TBL] [Abstract][Full Text] [Related]
39. Instrumental Variable Analyses and Selection Bias.
Canan C; Lesko C; Lau B
Epidemiology; 2017 May; 28(3):396-398. PubMed ID: 28169934
[TBL] [Abstract][Full Text] [Related]
40. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
